DeepMed Research

H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

Not Applicable

Completed

Conditions: Chemotherapy-induced Peripheral Neuropathy

Interventions: Device: Electroacupuncture
Device: NeuroMetrix
Device: Rydel-Seiffer tuning fork

First Posted Date: 2019-09-17

Last Posted Date: 2022-11-07

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 23

Registration Number: NCT04092764

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery

Completed

Conditions: GI Cancer
Nutritional Deficiency

Interventions: Other: My Plate Calorie Tracker

First Posted Date: 2019-09-16

Last Posted Date: 2023-04-11

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 23

Registration Number: NCT04091165

Locations: 🇺🇸
H Lee Moffitt Cancer & Research Institute, Tampa, Florida, United States

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

Recruiting

Conditions: Neuroendocrine Carcinoma

Interventions: Drug: 68Ga-DOTATATE
Diagnostic Test: Positron Emission Tomography (PET) Scan

First Posted Date: 2019-08-28

Last Posted Date: 2025-05-20

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 30

Registration Number: NCT04069299

Locations: 🇺🇸
H Lee Moffitt Cancer & Research Institute, Tampa, Florida, United States

Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas

Completed

Conditions: Glioma
Brain Tumor

Interventions: Device: Orbeye surgical videomicroscope
Drug: 5-Aminolevulinic Acid

First Posted Date: 2019-08-14

Last Posted Date: 2022-05-31

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 20

Registration Number: NCT04055688

Locations: 🇺🇸
H. Lee Moffitt Cancer and Research Institute, Tampa, Florida, United States

Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma

Phase 1

Completed

Conditions: Sarcoma

Interventions: Drug: TIL
Drug: Interleukin-2
Drug: Fludarabine
Drug: Cyclophosphamide

First Posted Date: 2019-08-09

Last Posted Date: 2025-04-17

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 9

Registration Number: NCT04052334

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma

Early Phase 1

Terminated

Conditions: Glioma of Brain

Interventions: Drug: Topotecan

First Posted Date: 2019-04-25

Last Posted Date: 2023-05-25

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 3

Registration Number: NCT03927274

Locations: 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

Modifying Diet to Improve Gut Microbiome

Not Applicable

Not yet recruiting

Conditions: Obesity

Interventions: Behavioral: DASH diet
Behavioral: standard American diet

First Posted Date: 2019-04-23

Last Posted Date: 2025-03-05

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 28

Registration Number: NCT03924778

Locations: 🇺🇸
Moffit Cancer Center, Tampa, Florida, United States

Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

Phase 1

Active, not recruiting

Conditions: Small Cell Lung Cancer Extensive Stage
Small-cell Lung Cancer

Interventions: Drug: Durvalumab
Drug: Olaparib Pill
Drug: Tremelimumab
Radiation: Thoracic Radiotherapy

First Posted Date: 2019-04-22

Last Posted Date: 2025-03-12

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 25

Registration Number: NCT03923270

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Phase 2

Terminated

Conditions: Angiosarcoma of Skin

Interventions: Drug: T-VEC

First Posted Date: 2019-04-19

Last Posted Date: 2022-11-01

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 5

Registration Number: NCT03921073

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES)

Completed

Conditions: Colorectal Cancer

Interventions: Behavioral: Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES) Materials
Behavioral: Contact Message
Behavioral: Personalized One on One Education
Diagnostic Test: Fecal Immunochemical Test (FIT)

First Posted Date: 2019-04-08

Last Posted Date: 2023-04-20

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 327

Registration Number: NCT03906110

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy